spacer
home > white papers > Modular Feeding Systems for Prefilled Syringes and Injection Devices - Dividella
WHITE PAPERS
logo_Dividellan.jpg

Dividella

phone +41 081 750 33 42
web http://www.dividella.com
email Werdenstrasse 76, CH-9472 Grabs

Modular Feeding Systems for Prefilled Syringes and Injection Devices

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
Modular Feeding Systems for Prefilled Syringes and Injection Devices
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

ERT Launches the Industrys First Multi-Language Diagnostic Platform for Respiratory Trials


More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>


Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement